Suchergebnisse - "JAK inhibitor"

PubPharm (3)

1

Current Insights on Lipid-Based Nanosystems 2023

Erschienen: Basel, MDPI - Multidisciplinary Digital Publishing Institute, 2023

von Silva, A. | Moreira, J. | Sousa Lobo, J.

2

Tofacitinib in treatment-refractory moderate to severe ulcerative colitis: real-world experience from a retrospective multicenter observational study

sonderdruck aus: Journal of clinical medicine | 2020

von Hoffmann, P. | Globig, A. | Thomann, A. | +5

3

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)

sonderdruck aus: BMC cancer | 2018

von Bubnoff, N. | Ihorst, G. | Grishina, O. | +5

1
[1]